[1]
Skovgaard Poulsen, H. et al. 2009. Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours. Acta Oncologica. 48, 1 (Jan. 2009), 52–58. DOI:https://doi.org/10.1080/02841860802537924.